Study participants
thrombosis, dementia, acute infectious diseases, nausea or dizziness, drug dependence
THROMBOSIS, CARDIOVASCULAR DISEASES, DISEASE, MOTION SICKNESS, INFLUENZA
The inclusion criteria were as follows: age of 18 years or older, haemodialysis duration more than 6 months, signed informed consent and sufficient eyesight. The exclusion criteria included cardiovascular diseases, electrical implants, metallic implants in the treatment area, susceptibility to nausea or dizziness (so-called "motion sickness"), potassium level > 7 mmol/l before intervention, acute infectious diseases (e.g., Covid-19 disease, influenza), alcohol and/or drug dependence (NMES not after alcohol consumption), increased risk of thrombosis and known dementia. Preliminary diagnoses and laboratory chemistry values were reviewed by the medical staff. Any signs of motion sickness were anamnestic and assessed by the medical staff.